PATENT CLAIM ANALYSIS

Application Number: 15864665
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-03
Patent Classification: ["514", "220000"]

Abstract:
Disclosed is a composition for the prevention or treatment of diabetic complications, containing a benzodiazepine-based compound, thereby effectively preventing or treating diseases resulting from hyperglycemia, which is the leading cause of diabetes, especially diseases caused by vascular leakage.

Claim (Index 4):
The method of  claim 1 , wherein the diabetic complications is caused by vascular leakage.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 86.0
- Lexical Diversity: 1.26471
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15593767', '13987543', '15335271', '11136254', '11297808']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7608055686431555
- 35 USC 102 Novelty (BERT): 0.5208680898504577
- Combined Prediction Score: 0.7368118207638857
- Mean Citation Score: 214.27957200000003
- Max Citation Score: 316.6147
- Similarity Product: 238.3224051817179

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test